Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer

Nature Genetics

Volumn 13, Issue 1, 1996, Pages 126-129

  Neuhausen, Susan ^b   Gilewski, Teresa ^a   Norton, Larry ^a   Tran, Thao ^b   McGuire, Peter ^a   Swensen, Jeff ^b   Hampel, Heather ^a   Borgen, Patrick ^a   Brown, Karen ^a   Skolnick, Mark ^c,d   Shattuck Eidens, Donna ^c   Jhanwar, Suresh ^a   Goldgar, David ^d   Offit, Kenneth ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c Myriad Genetics Laboratories Inc   (United States)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; PRIMER DNA; TRANSCRIPTION FACTOR; TUMOR PROTEIN;

ADULT; ARTICLE; BREAST TUMOR; FAMILY; FEMALE; GENE DELETION; GENETIC MARKER; GENETICS; HUMAN; JEW; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; OVARY TUMOR; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTOR;

ADULT; BASE SEQUENCE; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; DNA PRIMERS; FAMILY; FEMALE; GENETIC MARKERS; HUMANS; JEWS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTORS; SEQUENCE DELETION; TRANSCRIPTION FACTORS;

EID: 0030138354     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng0596-126     Document Type: Article

References (13)

1. Easton, D. et al Genetic linkage analysis in familial breast and ovarian cancer:results from 214 families Am J Hum Genet. 52, 678-701 (1993)
2. Wooster, R. et al Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265, 2088-2090 (1994)
3. Miki, Y. et al. A strong candidate gene for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66-71 (1994).
4. Struewing, J.P et al The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals Nature Genet 11, 198-200 (1995).
5. FitzGerald, M.G. et al. Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N. Engl. J. Med. 334, 143-149 (1996)
6. Offit, K et al. Germline BRCA1 185delAG mutations in Jewish women affected by breast cancer. Lancet (in the press).
7. Wooster, R. et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 378, 789-792 (1995)
8. Tavtigian, SV. et al. The BRCA2 gene and mutations in 13q-linked kindreds Nature Genet 12, 333-337 (1996).
9. Langston, A A. et al. BRCA1 mutations in a population-based sample of young women with early-onset breast cancer. N. Engl. J Med. 334, 137-142 (1996).
10. Offit, K & Brown K Quantitative risk counseling for familial cancer, a resource for clinical oncologists J Clin Oncol. 12, 1724-1736 (1994)
11. Saiki, RK et al Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230, 1350-1354 (1985)
12. Mullis, K. et al Specific enzymatic amplification of DNA in vitro, the polymerase chain reaction Cold Spring Harbor Symp. Quant Biol. 51, 263-273 (1986)
13. Weber, JL & May, PE Abundant class of human DNA polymorphism which can be typed using the polymerase chain reaction. Am. J. Hum. Genet. 44, 388-96 (1989)